Source: https://www.bankofengland.co.uk/-/media/boe/files/prudential-regulation/policy-statement/2026/january/ps126app1.pdf · captured 2026-09-29 · checked 2026-09-29 · c75b8196
10715 This document is effective from 1 January 2027 to accompany PS1/26.
10716Please see: www.bankofengland.co.uk/prudential-regulation/publication/2026/january/implementation-of-basel-3-1-final-rules-policy-statement.
10719 Articles 224 and 226, apply a 0% volatility adjustment. An institution using the SFT VaR Method
10720 shall not use the treatment set out in this Article.
10721 2. The conditions referred to in paragraph 1 are:
10722 (a) both the exposure and the collateral are cash or debt securities issued by central
10723 governments or central banks within the meaning of point (b) of paragraph 1 of Article 197
10724 and eligible for a 0% risk weight under the Credit Risk: Standardised Approach (CRR) Part
10725 or Article 114(7) of CRR;
10727 (b) both the exposure and the collateral are denominated in the same currency;
10729 (c) either the maturity of the transaction is no more than one day or both the exposure and the
10730 collateral are subject to daily marking-to-market or daily re-margining;
10732 (d) the time between the last marking-to-market before a failure to re-margin by the
10733 counterparty and the liquidation of the collateral is no more than four business days;
10735 (e) the transaction is settled in a settlement system proven for that type of transaction;
10737 (f) the documentation covering the agreement or transaction is standard market
10738 documentation for securities financing transactions in the securities concerned;
10740 (g) the transaction is governed by documentation specifying that where the counterparty fails
10741 to satisfy an obligation to deliver cash or securities or to deliver margin or otherwise
10742 defaults, then the transaction is immediately terminable;
10744 (h) the counterparty is a core market participant, as set out in paragraph 3;
10746 (i) upon any default event, including in the event of the bankruptcy or insolvency of the
10747 counterparty, the institution has an unfettered, enforceable right immediately to seize and
10748 liquidate the collateral for its benefit.
10750 3. The following entities are core market participants:
10751 (a) the entities referred to in point (b) of paragraph 1 of Article 197 where exposures to such
10752 entities would be assigned a 0% risk weight under the Credit Risk: Standardised Approach
10753 (CRR) Part or under Article 114(7) of CRR;
10757 (ba) financial institutions exposures to which may be treated as exposures to institutions under
10758 Article 119(5) of CRR;
10760 (c) other financial undertakings that are an insurance undertaking or reinsurance undertaking,
10761 an insurance holding company or a mixed financial holding company, where:
10763 (i) such financial undertaking has a credit assessment by an ECAI and exposures to it
10764 would be assigned a 20% risk weight under the Standardised Approach; or
10766 (ii) in the case of exposures where an institution calculates risk-weighted exposure
10767 amounts and expected loss amounts using the IRB Approach, such financial
10768 undertaking is internally rated by the institution using the IRB Approach and the
10769 internal rating indicates comparable or better credit quality than a credit assessment
10770 by an ECAI that would result in the condition in point (i) being met;
10772 (d) regulated CIUs that are subject to capital or leverage requirements;